Nucleic acid ligands act as a PAM and agonist depending on the intrinsic ligand binding state of P2RY2
Author(s) -
Masaki Takahashi,
R. S. Amano,
Michiru Ozawa,
Anna Martinez,
Kazumasa Akita,
Yoshikazu Nakamura
Publication year - 2021
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2019497118
Subject(s) - g protein coupled receptor , aptamer , nucleic acid , allosteric regulation , ligand (biochemistry) , agonist , receptor , chemistry , allosteric modulator , biochemistry , drug discovery , biology , microbiology and biotechnology
Significance Discovery of ligands for G protein–coupled receptors (GPCRs) is of importance in receptor biology and pharmacology but is still a challenging issue. Here, we propose a method for the discovery of ligands against GPCRs by employing a virus-like particle (VLP) and show unique properties of identified nucleic acid aptamers for GPCR. One aptamer raised against purinergic receptor P2Y2 (P2RY2), a GPCR, behaves like a partial agonist to unliganded receptor, whereas it exhibits a positive allosteric modulator (PAM) activity to liganded receptor. We demonstrate the validity of our aptamer screening method targeting VLP-stabilized GPCR and a unique aptamer with dual function, agonist and PAM, for GPCR, depending on whether the intrinsic ligand is prebound to the receptor.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom